Literature DB >> 8710411

Hypoxanthine: a low molecular weight factor essential for growth of erythrocytic Plasmodium falciparum in a serum-free medium.

H Asahi1, T Kanazawa, Y Kajihara, K Takahashi, T Takahashi.   

Abstract

A low molecular weight factor in a basal medium essential for erythrocytic Plasmodium falciparum development in a serum-free medium using a cell growth-promoting factor derived from adult bovine serum was detected. The factor was hypoxanthine. The optimal hypoxanthine concentration for parasite growth was between 15 and 120 microM. The contribution of hypoxanthine to increased parasite growth was clearly evident in cultures on day 4. Among various low molecular weight supplements tested, adenine, adenosine, AMP, ATP, cyclic AMP, guanine, guanosine, inosine, inosine monophosphate, xanthine, NAD, NADH, NADP, NADPH and deoxyguanosine triphosphate showed a similar effect to that of hypoxanthine in the serum-free culture system. On the other hand, the addition of uric acid, FAD, thymidine, uridine, orotic acid, deoxythymidine triphosphate, deoxycytidine triphosphate, deoxyadenosine triphosphate, ribose-1-phosphate, or ethanolamine was not beneficial to the parasite growth. The results presented here will not only be of practical value, but will provide important information about the developmental requirements of the parasite.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8710411     DOI: 10.1017/s0031182000066233

Source DB:  PubMed          Journal:  Parasitology        ISSN: 0031-1820            Impact factor:   3.234


  17 in total

Review 1.  A surprising role for uric acid: the inflammatory malaria response.

Authors:  Julio Gallego-Delgado; Maureen Ty; Jamie M Orengo; Diana van de Hoef; Ana Rodriguez
Journal:  Curr Rheumatol Rep       Date:  2014-02       Impact factor: 4.592

Review 2.  Purine salvage pathways in the intraerythrocytic malaria parasite Plasmodium falciparum.

Authors:  Megan J Downie; Kiaran Kirk; Choukri Ben Mamoun
Journal:  Eukaryot Cell       Date:  2008-06-20

3.  Solute restriction reveals an essential role for clag3-associated channels in malaria parasite nutrient acquisition.

Authors:  Ajay D Pillai; Wang Nguitragool; Brian Lyko; Keithlee Dolinta; Michelle M Butler; Son T Nguyen; Norton P Peet; Terry L Bowlin; Sanjay A Desai
Journal:  Mol Pharmacol       Date:  2012-09-04       Impact factor: 4.436

Review 4.  Why do malaria parasites increase host erythrocyte permeability?

Authors:  Sanjay A Desai
Journal:  Trends Parasitol       Date:  2014-02-05

5.  Molecular dynamics studies of a hexameric purine nucleoside phosphorylase.

Authors:  Fernando Berton Zanchi; Rafael Andrade Caceres; Rodrigo Guerino Stabeli; Walter Filgueira de Azevedo
Journal:  J Mol Model       Date:  2009-08-11       Impact factor: 1.810

6.  Assessment of the drug susceptibility of Plasmodium falciparum clinical isolates from africa by using a Plasmodium lactate dehydrogenase immunodetection assay and an inhibitory maximum effect model for precise measurement of the 50-percent inhibitory concentration.

Authors:  Halima Kaddouri; Serge Nakache; Sandrine Houzé; France Mentré; Jacques Le Bras
Journal:  Antimicrob Agents Chemother       Date:  2006-10       Impact factor: 5.191

7.  Plasmodium falciparum purine nucleoside phosphorylase is critical for viability of malaria parasites.

Authors:  Dennis C Madrid; Li-Min Ting; Karena L Waller; Vern L Schramm; Kami Kim
Journal:  J Biol Chem       Date:  2008-10-28       Impact factor: 5.157

8.  Efficient syntheses of 5'-deoxy-5'-fluoroguanosine and -inosine.

Authors:  Robert C Spitale; Moriah G Heller; Amanda J Pelly; Joseph E Wedekind
Journal:  J Org Chem       Date:  2007-09-29       Impact factor: 4.354

Review 9.  Insights gained from P. falciparum cultivation in modified media.

Authors:  Sanjay A Desai
Journal:  ScientificWorldJournal       Date:  2013-07-09

10.  Plasmodium-induced inflammation by uric acid.

Authors:  Jamie M Orengo; James E Evans; Esther Bettiol; Aleksandra Leliwa-Sytek; Karen Day; Ana Rodriguez
Journal:  PLoS Pathog       Date:  2008-03-07       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.